- New: Monkeypox Vaccination in Adults With HIV (7/29/22)
- New Guidance: Drug-Drug Interactions: ARVs and Treatments for Severe Monkeypox (7/15/22)
- Medscape Commentary: Screening for Cervical Dysplasia and Cancer in Adults With HIV (7/6/22)
- Statement on Use of Long-Acting Injectable CAB/RPV as First-Line ART (7/5/22)
- Topics, Trends & Updates for June (6/2/22)
- Updated: PrEP to Prevent HIV and Promote Sexual Health (5/23/22)
- Updated: HIV Testing (5/20/22)
- CDC: Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 (8/8/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents (8/2/22)
- New: Monkeypox Vaccination in Adults With HIV (7/29/22)
- CDC Dear Colleague Letter: Pain Associated With Monkeypox Anogenital Lesions (7/28/22)
- NYSDOH: Monkeypox Resources for Healthcare Providers (7/26/22)
- CDC: Information for Healthcare Providers on Obtaining and Using TPOXX for Treatment of Monkeypox (7/25/22)
- NYCDOHMH Health Advisory: Update on Monkeypox in New York City (7/18/22)
- AETC NCRC: Updates from AETC Program Colleagues & Friends - August 2022 (8/8/22)
- CEI Newsletter (8/2/22)
- HIVinfo: HIV and Pregnancy Resources Available (7/28/22)
- NYSDOH: Hepatitis C (HCV) Learning Collaborative (7/18/22)
- NYSDOH AI: 2022 ETE Summit Call for Abstracts (7/12/22)
- NYS Medicaid Update – June (7/12/22)
- NYSDOH AI: "Beyond Status" New HIV Testing Webpage (7/5/22)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders.
Learn more: